Vericel Corp (NASDAQ:VCEL)

Data as of Jan 28
 0.00 / 0.00%
Today’s Change
Today|||52-Week Range
Health Technology
Medical Specialties

Company Description

Vericel Corp. is a regenerative medicine company which engages in the development of patient-specific, expanded multicellular therapies for use in the treatment of severe, chronic ischemic cardiovascular diseases. The company's research and product development involves in the development of patient specific cell products for use in regenerative medicine. Its proprietary cell-manufacturing technology enables the manufacture of Ixmyelocel-T, a patient-specific, multicellular therapy, expanded from an adult's own bone marrow, and delivered directly to damaged tissues. Vericel was founded on March 24, 1989 and is headquartered in Cambridge, MA.

Contact Information

Vericel Corp.
64 Sidney Street
Cambridge Massachusetts 02139
P:(617) 252-7999
Investor Relations:



Other institutional47.58%
Mutual fund holders3.91%
Individual stakeholders0.21%

Top Executives

Dominick C. ColangeloPresident, CEO, Treasurer, Director & CAO
Daniel R. OrlandoChief Operating Officer
Gerard J. MichelChief Financial Officer & VP-Corporate Development
David ReckerChief Medical Officer
Ross TuboChief Scientific Officer

Most stock quote data provided by BATS. Market indices are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer.

Morningstar: © 2015 Morningstar, Inc. All Rights Reserved.

Factset: FactSet Research Systems Inc. 2015. All rights reserved.

Chicago Mercantile Association: Certain market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved.

Dow Jones: The Dow Jones branded indices are proprietary to and are calculated, distributed and marketed by DJI Opco, a subsidiary of S&P Dow Jones Indices LLC and have been licensed for use to S&P Opco, LLC and CNN. Standard & Poor's and S&P are registered trademarks of Standard & Poor’s Financial Services LLC and Dow Jones is a registered trademark of Dow Jones Trademark Holdings LLC. All content of the Dow Jones branded indices © S&P Dow Jones Indices LLC 2015 and/or its affiliates.